ReShape Lifesciences Inc. (RSLS)
USD 0.49
(29.26%)
USD 0.49
(29.26%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 3.74 Million USD | 3.6% |
| 2022 | 3.61 Million USD | 20.25% |
| 2021 | 3 Million USD | 33.82% |
| 2020 | 2.24 Million USD | 70.39% |
| 2019 | 1.31 Million USD | 33.74% |
| 2018 | 984.73 Thousand USD | -65.04% |
| 2017 | 2.81 Million USD | 57.37% |
| 2016 | 1.79 Million USD | 6.17% |
| 2015 | 1.68 Million USD | 71.87% |
| 2014 | 981 Thousand USD | -13.03% |
| 2013 | 1.12 Million USD | -11.25% |
| 2012 | 1.27 Million USD | 18.94% |
| 2011 | 1.06 Million USD | 0.0% |
| 2010 | - USD | 100.0% |
| 2009 | -14.14 Million USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 3.46 Million USD | -7.32% |
| 2024 Q2 | 3.24 Million USD | -6.37% |
| 2023 Q1 | 3.49 Million USD | -3.27% |
| 2023 FY | 3.74 Million USD | 3.6% |
| 2023 Q4 | 3.74 Million USD | 16.76% |
| 2023 Q3 | 3.2 Million USD | -1.96% |
| 2023 Q2 | 3.26 Million USD | -6.44% |
| 2022 Q4 | 3.61 Million USD | -13.43% |
| 2022 Q2 | 4.22 Million USD | 5.7% |
| 2022 Q1 | 3.99 Million USD | 33.13% |
| 2022 FY | 3.61 Million USD | 20.25% |
| 2022 Q3 | 4.17 Million USD | -1.3% |
| 2021 Q1 | 2.09 Million USD | -6.64% |
| 2021 FY | 3 Million USD | 33.82% |
| 2021 Q3 | 3.2 Million USD | 10.78% |
| 2021 Q2 | 2.89 Million USD | 38.14% |
| 2021 Q4 | 3 Million USD | -6.33% |
| 2020 Q2 | 2.08 Million USD | 65.47% |
| 2020 FY | 2.24 Million USD | 70.39% |
| 2020 Q1 | 1.25 Million USD | -4.56% |
| 2020 Q4 | 2.24 Million USD | 12.88% |
| 2020 Q3 | 1.98 Million USD | -4.42% |
| 2019 Q3 | 1.18 Million USD | -11.8% |
| 2019 FY | 1.31 Million USD | 33.74% |
| 2019 Q4 | 1.31 Million USD | 10.77% |
| 2019 Q1 | 1.02 Million USD | 4.09% |
| 2019 Q2 | 1.34 Million USD | 31.51% |
| 2018 Q3 | 1.05 Million USD | -49.66% |
| 2018 Q1 | 2.79 Million USD | -0.77% |
| 2018 FY | 984.73 Thousand USD | -65.04% |
| 2018 Q4 | 984.73 Thousand USD | -6.9% |
| 2018 Q2 | 2.1 Million USD | -24.84% |
| 2017 Q1 | 1.7 Million USD | -4.86% |
| 2017 FY | 2.81 Million USD | 57.37% |
| 2017 Q4 | 2.81 Million USD | 77.55% |
| 2017 Q3 | 1.58 Million USD | 11.97% |
| 2017 Q2 | 1.41 Million USD | -16.79% |
| 2016 Q3 | 2.13 Million USD | 8.99% |
| 2016 Q4 | 1.79 Million USD | -16.12% |
| 2016 FY | 1.79 Million USD | 6.17% |
| 2016 Q2 | 1.95 Million USD | 4.81% |
| 2016 Q1 | 1.86 Million USD | 10.81% |
| 2015 Q4 | 1.68 Million USD | 22.53% |
| 2015 FY | 1.68 Million USD | 71.87% |
| 2015 Q1 | 1.12 Million USD | 14.78% |
| 2015 Q3 | 1.37 Million USD | 7.13% |
| 2015 Q2 | 1.28 Million USD | 14.07% |
| 2014 Q4 | 981 Thousand USD | 7.15% |
| 2014 FY | 981 Thousand USD | -13.03% |
| 2014 Q3 | 915.49 Thousand USD | 2.26% |
| 2014 Q2 | 895.27 Thousand USD | -17.94% |
| 2014 Q1 | 1.09 Million USD | -3.28% |
| 2013 Q2 | 1.35 Million USD | 1.65% |
| 2013 Q1 | 1.33 Million USD | 5.11% |
| 2013 Q4 | 1.12 Million USD | -3.75% |
| 2013 FY | 1.12 Million USD | -11.25% |
| 2013 Q3 | 1.17 Million USD | -13.7% |
| 2012 Q2 | 1.08 Million USD | 8.5% |
| 2012 Q4 | 1.27 Million USD | -21.1% |
| 2012 FY | 1.27 Million USD | 18.94% |
| 2012 Q1 | 1 Million USD | -6.16% |
| 2012 Q3 | 1.61 Million USD | 48.07% |
| 2011 Q4 | 1.06 Million USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 FY | 1.06 Million USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q4 | - USD | 100.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 100.0% |
| 2010 Q3 | -12.23 Million USD | 0.0% |
| 2009 FY | -14.14 Million USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 3.31 Million USD | -13.021% |
| BrainsWay Ltd. | 3.71 Million USD | -0.646% |
| Cerus Corporation | 39.86 Million USD | 90.617% |
| Envoy Medical, Inc. | 1.4 Million USD | -166.453% |
| electroCore, Inc. | 2.16 Million USD | -73.194% |
| Helius Medical Technologies, Inc. | 457 Thousand USD | -718.6% |
| IceCure Medical Ltd | 2.27 Million USD | -64.44% |
| Inogen, Inc. | 21.84 Million USD | 82.871% |
| OrthoPediatrics Corp. | 105.85 Million USD | 96.466% |
| Lucid Diagnostics Inc. | 278 Thousand USD | -1245.683% |
| Monogram Orthopaedics, Inc. | 1.00 USD | -374099900.0% |
| MaxCyte, Inc. | 12.22 Million USD | 69.409% |
| NeuroOne Medical Technologies Corporation | 1.72 Million USD | -116.658% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -2291.638% |
| Orthofix Medical Inc. | 222.16 Million USD | 98.316% |
| PAVmed Inc | 1.01 Million USD | -267.847% |
| Rapid Micro Biosystems, Inc. | 19.96 Million USD | 81.258% |
| RxSight, Inc. | 17.42 Million USD | 78.526% |
| Sight Sciences, Inc. | 7.84 Million USD | 52.338% |
| SI-BONE, Inc. | 20.24 Million USD | 81.525% |
| TELA Bio, Inc. | 13.16 Million USD | 71.577% |
| Treace Medical Concepts, Inc. | 29.24 Million USD | 87.208% |
| Vivos Therapeutics, Inc. | 1.00 USD | -374099900.0% |
| Acutus Medical, Inc. | 4.27 Million USD | 12.553% |
| Talis Biomedical Corporation | - USD | -Infinity% |
| Spectral AI, Inc. | 230 Thousand USD | -1526.522% |
| Nano-X Imaging Ltd. | 2.35 Million USD | -58.786% |
| CVRx, Inc. | 10.98 Million USD | 65.938% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 390.07 Thousand USD | -859.044% |
| Bioventus Inc. | 91.33 Million USD | 95.904% |
| Venus Concept Inc. | 28.67 Million USD | 86.954% |
| TriSalus Life Sciences, Inc. | 2.54 Million USD | -46.994% |
| LivaNova PLC | 147.88 Million USD | 97.47% |
| 908 Devices Inc. | 14.93 Million USD | 74.956% |
| Alphatec Holdings, Inc. | 136.84 Million USD | 97.266% |
| Nemaura Medical Inc. | 1.75 Million USD | -113.18% |
| NeuroPace, Inc. | 11.21 Million USD | 66.64% |
| LENSAR, Inc. | 15.68 Million USD | 76.155% |
| Apyx Medical Corporation | 9.92 Million USD | 62.3% |
| Cutera, Inc. | 72.1 Million USD | 94.811% |
| STRATA Skin Sciences, Inc. | 2.67 Million USD | -39.955% |
| BioSig Technologies, Inc. | -103 Thousand USD | 3732.039% |
| Anika Therapeutics, Inc. | 46.38 Million USD | 91.935% |
| ClearPoint Neuro, Inc. | 7.91 Million USD | 52.711% |
| Integra LifeSciences Holdings Corporation | 389.6 Million USD | 99.04% |
| Axonics, Inc. | 79.94 Million USD | 95.32% |
| Outset Medical, Inc. | 49.21 Million USD | 92.399% |
| IRIDEX Corporation | 9.9 Million USD | 62.235% |
| PROCEPT BioRobotics Corporation | 39.75 Million USD | 90.59% |
| IRadimed Corporation | 12.82 Million USD | 70.822% |
| Tivic Health Systems, Inc. | 756 Thousand USD | -394.841% |
| INVO Bioscience, Inc. | 264.5 Thousand USD | -1314.329% |
| Telesis Bio, Inc. | 4.02 Million USD | 7.056% |
| Viemed Healthcare, Inc. | 4.6 Million USD | 18.75% |
| Varex Imaging Corporation | 277.5 Million USD | 98.652% |
| Quipt Home Medical Corp. | 18.32 Million USD | 79.586% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 16.74 Million USD | 77.656% |
| Dynatronics Corporation | 5.59 Million USD | 33.124% |
| Modular Medical, Inc. | - USD | -Infinity% |
| Semler Scientific, Inc. | 445 Thousand USD | -740.674% |
| InMode Ltd. | 45.09 Million USD | 91.704% |
| Bruker Corporation | 968.3 Million USD | 99.614% |
| Cytosorbents Corporation | 3.68 Million USD | -1.654% |
| DexCom, Inc. | 559.6 Million USD | 99.331% |
| Align Technology, Inc. | 296.9 Million USD | 98.74% |
| Viveve Medical, Inc. | 1.47 Million USD | -154.144% |
| ZimVie Inc. | 79.6 Million USD | 95.3% |
| Movano Inc. | 1.51 Million USD | -147.257% |
| Cytek Biosciences, Inc. | 60.87 Million USD | 93.855% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -2291.638% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 157.93 Million USD | 97.631% |
| Profound Medical Corp. | 6.95 Million USD | 46.198% |
| Insulet Corporation | 402.6 Million USD | 99.071% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 14.83 Million USD | 74.789% |
| iCAD, Inc. | 917 Thousand USD | -307.961% |
| Nuwellis, Inc. | 1.99 Million USD | -87.331% |
| Biotricity, Inc. | 1.87 Million USD | -99.053% |
| iRhythm Technologies, Inc. | 13.97 Million USD | 73.227% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 2.1 Million USD | -77.635% |
| PAVmed Inc. | 1.01 Million USD | -267.847% |
| BIOLASE, Inc. | 11.43 Million USD | 67.279% |
| Beyond Air, Inc. | 2.12 Million USD | -75.882% |
| FONAR Corporation | 2.71 Million USD | -37.768% |
| AxoGen, Inc. | 23.02 Million USD | 83.749% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 22.52 Million USD | 83.393% |
| Inari Medical, Inc. | 42.9 Million USD | 91.28% |
| UFP Technologies, Inc. | 70.19 Million USD | 94.67% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 629.17 Thousand USD | -494.584% |
| Tenon Medical, Inc. | 554 Thousand USD | -575.271% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 1.66 Million USD | -124.722% |
| AdaptHealth Corp. | 113.64 Million USD | 96.708% |
| Sintx Technologies, Inc. | 888 Thousand USD | -321.284% |
| NanoVibronix, Inc. | 2.73 Million USD | -36.933% |
| Quanterix Corporation | 22.36 Million USD | 83.273% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 14.84 Million USD | 74.803% |
| Pacific Biosciences of California, Inc. | 56.67 Million USD | 93.399% |
| TransMedics Group, Inc. | 44.23 Million USD | 91.543% |
| ReWalk Robotics Ltd. | 5.65 Million USD | 33.823% |
| NeuroMetrix, Inc. | 1.55 Million USD | -139.896% |
| Hyperfine, Inc. | 6.58 Million USD | 43.163% |
| Establishment Labs Holdings Inc. | 79.93 Million USD | 95.32% |
| Biomerica, Inc. | 2.37 Million USD | -57.449% |
| Bone Biologics Corporation | -328.84 Thousand USD | 1237.621% |
| AVITA Medical, Inc. | 3.12 Million USD | -19.85% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 29.87 Million USD | 87.478% |